Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells - ScienceDirect
Role of PAI-1 in fibrinolytic system. | Download Scientific Diagram
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
IJMS | Free Full-Text | PAI-1, the Plasminogen System, and Skeletal Muscle
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship | Diabetology & Metabolic Syndrome | Full Text
PAI-1 Assays
Plasminogen activator inhibitor-1 and the kidney | American Journal of Physiology-Renal Physiology
PDF] Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. | Semantic Scholar
PAI-1 inhibitor: RS5614 | Renascience
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
IJMS | Free Full-Text | PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target